These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12420342)

  • 1. [Markers of oxidative damage in blood of children with cystic fibrosis].
    Chełchowska M; Laskowska-Klita T; Nowaczewska I; Narolewska U
    Pol Merkur Lekarski; 2002 Aug; 13(74):123-5. PubMed ID: 12420342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for increased oxidative damage in patients with cystic fibrosis.
    Brown RK; Kelly FJ
    Pediatr Res; 1994 Oct; 36(4):487-93. PubMed ID: 7816524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
    Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
    Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis.
    Rust P; Eichler I; Renner S; Elmadfa I
    Int J Vitam Nutr Res; 1998; 68(2):83-7. PubMed ID: 9565821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individuals with cystic fibrosis do not display impaired endothelial function or evidence of oxidative damage in endothelial cells exposed to serum.
    McGrath LT; McCall D; Hanratty CG; Brennan S; Devine A; McCauley DF; Silke B; Elborn S
    Clin Sci (Lond); 2001 Nov; 101(5):507-13. PubMed ID: 11672456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of nutrient absorption may enhance systemic oxidative stress in cystic fibrosis patients.
    Shmarina GV; Pukhalsky AL; Kokarovtseva SN; Pukhalskaya DA; Kalashnikova EA; Kapranov NI; Kashirskaja NJ
    Mediators Inflamm; 2001 Apr; 10(2):61-7. PubMed ID: 11405551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
    Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional supplement attenuates selected oxidative stress markers in pediatric patients with cystic fibrosis.
    Sadowska-Woda I; Rachel M; Pazdan J; Bieszczad-Bedrejczuk E; Pawliszak K
    Nutr Res; 2011 Jul; 31(7):509-18. PubMed ID: 21840467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis.
    Langley SC; Brown RK; Kelly FJ
    Pediatr Res; 1993 Mar; 33(3):247-50. PubMed ID: 8460060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major.
    Naithani R; Chandra J; Bhattacharjee J; Verma P; Narayan S
    Pediatr Blood Cancer; 2006 Jun; 46(7):780-5. PubMed ID: 16317757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in patients with essential hypertension.
    Tandon R; Sinha MK; Garg H; Khanna R; Khanna HD
    Natl Med J India; 2005; 18(6):297-9. PubMed ID: 16483028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid peroxidation and catalase in diabetes mellitus with and without ischemic stroke.
    Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M; Lazăr L; Drută A
    Rom J Intern Med; 2004; 42(2):423-9. PubMed ID: 15529632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Obesity and its' influence on reactive oxygen species (ROS) in the blood of patients with varicose veins of the lower limbs].
    Kózka M; Krzyściak W; Pietrzycka A; Stepniewski M
    Przegl Lek; 2009; 66(5):213-7. PubMed ID: 19739576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary profile and oxidative stress in children and adolescents with cystic fibrosis.
    Livnat G; Bentur L; Kuzmisnsky E; Nagler RM
    J Oral Pathol Med; 2010 Jan; 39(1):16-21. PubMed ID: 19656266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis.
    Hakim F; Kerem E; Rivlin J; Bentur L; Stankiewicz H; Bdolach-Abram T; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):347-53. PubMed ID: 17873748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation and total antioxidant status in patients with breast cancer.
    Sener DE; Gönenç A; Akinci M; Torun M
    Cell Biochem Funct; 2007; 25(4):377-82. PubMed ID: 16447143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis.
    Baskol G; Demir H; Baskol M; Kilic E; Ates F; Karakukcu C; Ustdal M
    Cell Biochem Funct; 2006; 24(4):307-11. PubMed ID: 16142689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Concentration of plasma beta-carotene in cystic fibrosis children with pancreatic insufficiency].
    Laskowska-Klita T; Chełchowska M
    Med Wieku Rozwoj; 2002; 6(3):267-72. PubMed ID: 12637781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.